Meet the German HealthCapital Berlin-Brandenburg

12–15 May 2025 | Barcelona, Spain

Register
Register
Register

IMMUNEO Therapeutics GmbH

Industry & Private Sector

www.immuneo-therapeutics.de/Brandenburg an der Havel, Germany
5 profile visits

About

Our focus on developing highly targeted and effective immunizations aims to set a new standard of care, working towards a future where cancer and serious infections no longer have to be life-altering conditions. Behind this mission is a team driven by expertise, innovation, and a shared vision.

Social media

INDUSTRY: GE_Healthcare

GE1-Medical biotechnologyGE3-Health serviceCH2-Pharmaceuticals, diagnostics

BUSINESS ACTIVITY

ApplicationR & DAdvisory / Consulting

INDUSTRY: MT_Medical_technology

MT3-Medical Devices

Additional questions

General cooperation interests

Other (please specify)Delivery of products/servicesJoint investments/joint ventureR&D CooperationHigh-skilled talent attractionProject consortia for funding

Other cooperation interests - Please specify (Optional)

Clinical trial cooperation

Representatives

Mari Carmen Martos

Head of Bioinformatics

IMMUNEO Therapeutics GmbH

Mauro Nogueira, Dr. rer. nat.

Senior Regulatory Affairs Strategist

IMMUNEO Therapeutics GmbH

Marketplace (3)

  • Service

    BISS platform

    We provide clinical decision support, adjuvant early stage diagnostics and mono/combi BITAP therapy within our BISS platform.

    • Innovation
    • Development
    Author

    Mari Carmen Martos

    Head of Bioinformatics at IMMUNEO Therapeutics GmbH

    Brandenburg an der Havel, Germany

  • Investment

    Immuneo Therapeutics investment opportunity

    Immuneo Therapuetic goal is to create innovative, precise, and personalized solutions designed to address the needs of patients.

    • Startup
    • Expansion
    • Growth and Establishment
    Author

    Mari Carmen Martos

    Head of Bioinformatics at IMMUNEO Therapeutics GmbH

    Brandenburg an der Havel, Germany